Table 1.

Flow analysis of leukocytes infiltrating solid Stage III/IV human ovarian tumors

PatientsGated on CD45Gated on CD11c+HLA-DR+Gated on Dec205Gated on CD45
CD11c+CD11c+HLA-DR+Dec205+Dec205CD11b+CD14+CD20+CD3+
S1 Patient 15230.939.961.728.61.7830.9
S2 Patient 247.247.159.139.429.22.7945.7
S4 Patient 3 (P)84.782.217.281.24.9n/an/a
S5 Patient 3 (M)84.856.31276.815.6n/an/a
S6 Patient 41212.370.330.144.5n/an/a
S7 Patient 557.156.570.325.821.5n/an/a
S8 Patient 652.852.441.359.97.041.7830.9
S9 Patient 741.740n/an/an/a0.2710.2
S10 Patient 828.26.35n/an/an/a0.0130.49
S11 Patient 937.236.5n/an/an/a2.858.34
S12 Patient 1037.15.4n/an/an/a0.0451.92
  • Gating strategy is outlined in Fig. 2 H. n/a, insufficient material. Values are expressed as percentages.